All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

Our financial data in facts & figures

OUR GROUP REVENUES

EBITDA (2022)

77.2 (18.7% of turnover)

EBIT (2022)

51.7 (12.5% of turnover)

NET RESULT (2022)

37.8 (9.2% of turnover)

Related Documents

Discover more

OUR GROUP FIGURES BY FOCUS AREA (€ Millions, 2022)

153,867086621844 € Millions

JOINT CARE

82,1561191426405 € Millions

EYE CARE

47,5369888949927 € Millions

SKIN CARE

34,32201781 € Millions

CORTICOSTEROIDS

5,14874152 € Millions

ACTIVE SUBSTANCES

89,0428558104953 € Millions

OTHER

OUR FIGURES BY PRODUCT CATEGORY (2022)

PRESCRIPTION DRUGS

MEDICAL DEVICES

VACCINES

OTHER

OUR GROUP FIGURES BY GEOGRAPHICAL AREA (€ Millions, 2022)

216,248749479973 € Millions

ITALY

112,71258268 € Millions

EUROPE

58,39774655 € Millions

USA

15,75664826 € Millions

MENA

6,95807983 € Millions

RoW

OUR GROUP

GOVERNANCE

Find out more